Synthomer (LON:SYNT – Free Report) had its price target lifted by Berenberg Bank from GBX 100 to GBX 110 in a research note issued to investors on Friday, Marketbeat Ratings reports. They currently have a hold rating on the stock.
Several other brokerages have also recently issued reports on SYNT. Jefferies Financial Group reiterated a “hold” rating and issued a GBX 65 price target on shares of Synthomer in a research note on Thursday, April 30th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 200 price objective on shares of Synthomer in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Synthomer from GBX 92 to GBX 100 and gave the stock a “hold” rating in a report on Wednesday. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of GBX 119.
Read Our Latest Report on SYNT
Synthomer Price Performance
Synthomer (LON:SYNT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported GBX (4.30) earnings per share (EPS) for the quarter. Synthomer had a negative net margin of 6.81% and a negative return on equity of 13.27%. As a group, sell-side analysts predict that Synthomer will post 12.962963 earnings per share for the current year.
About Synthomer
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Further Reading
- Five stocks we like better than Synthomer
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.
